[ad_1]
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Convention Name December 10, 2024 10:30 AM ET
Firm Contributors
Jennifer Tub – CEOKristin Taylor – CFO
Convention Name Contributors
Swayampakula Ramakanth – H.C. WainwrightWilliam McHale – Ingalls & Snyder
Operator
Good morning, women and gents, and thanks for becoming a member of us as we speak for ImmunoPrecise Antibodies Second Quarter Fiscal 12 months 2025 Earnings Name. We respect your time and curiosity in IPA.
At this time’s name will probably be led by our CEO, Dr. Jennifer Tub; and our CFO, Kristin Taylor. They are going to present a evaluation of our monetary efficiency, strategic initiatives and key operational highlights for the quarter.
Please notice {that a} copy of as we speak’s presentation, together with our monetary statements will probably be out there on our firm web site to your reference. We encourage you to evaluation these supplies to achieve a deeper understanding of our efficiency and strategic course. As soon as once more, thanks for becoming a member of us as we speak. We stay up for sharing our progress and discussing our future plans with you.
Earlier than we proceed, I wish to remind everybody that as we speak’s dialogue will include forward-looking statements. These statements are primarily based on present expectations and assumptions which are topic to dangers and uncertainties. Precise outcomes may differ materially from these anticipated because of varied components, together with, however not restricted to adjustments in market circumstances, regulatory adjustments and different unexpected enterprise dangers. Please notice that these forward-looking statements are made as of as we speak and we undertake no obligation to replace them on account of new data or future occasions until required by legislation. We strongly advise all members to seek advice from our filings with the Securities and Alternate Fee, SEC, together with our most up-to-date Type 20-F, and different periodic stories, for a extra detailed dialogue of those dangers and uncertainties and for a extra full understanding of the dangers inherent in our enterprise operations and the
[ad_2]
Source link
